Operationalising Factors That Explain the Emergence of Infectious Diseases: A Case Study of the Human Campylobacteriosis Epidemic by Norval J. C. Strachan (235193)

“…The study focused on Scotland between 1990–2012 where there was a 75% increase in reported cases that included >300% increase in the elderly and 50% decrease in young children. …”

Table_4_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”

Table_3_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”

A Mixed-Method Approach for Quantifying Illegal Fishing and Its Impact on an Endangered Fish Species by Christopher M. Free (463223)

“…Of the five species sampled in the monitoring program, only burbot (<i>Lota lota</i>) showed a significant decrease in population abundance from 2009–2013. …”

Analysis of BCL11A gene polymorphisms and hemolysis parameters in patients with sickle-cell disease by Marilia R. Laurentino (5629814)

“…The use of HU at doses ≥ 10 mg/kg/day showed a decrease of LDH (p = 0.02), and treatment for > 50 months was linked to the reticulocyte count (p = 0.0155). …”

Table_5_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX by Phillip E. Vlisides (6740489)

“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”

Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial by Samuel Oliveira de Afonseca (12798419)

“…Previous studies have shown that vitamin E can reduce the incidence of peripheral neuropathy by 50%. This study aimed to assess the effectiveness of vitamin E for prevention of oxaliplatin-induced peripheral neuropathy.DESIGN AND SETTINGProspective, phase II, randomized pilot study developed at a university hospital in the Greater ABC region.METHODSPatients were randomized five days before starting oxaliplatin treatment, to receive either vitamin E or placebo until the end of the chemotherapy regimen. …”

Rab7A depletion affects Env processing and the incorporation of mature Env into viral particles. by Marina Caillet (198168)

“…This experiment is representative of 3 independent experiments done in duplicate. (<b>A</b>) Equal amounts of cell lysate (50 µg protein) were loaded to visualize the intracellular accumulation of viral proteins in Rab7A-depleted cells. …”

Supplementary Material for: Alcohol use and types and ischemic stroke: a systematic review and meta-analysis by figshare admin karger (2628495)

“…Conclusions: Our analysis provided a strong and robust evidence that there was a significant association between moderate and heavy alcohol use with ischemic stroke risk. …”

Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”

Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”

Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”

Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”

Recognition of Small Polar Molecules with an Ionic Crystal of α-Keggin-Type Polyoxometalate with a Macrocation by Sayaka Uchida (115177)

“…The space volumes of the ionic crystals decrease in the order of <b>1a</b> > <b>2a</b> > <b>3a</b> > <b>4a</b>. …”

<i>Tg</i>6PGDH2 is important for parasite survival. by Ningbo Xia (13584299)

Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Wound Healing in Type 2 Diabetes - F... by Aurore Lafosse (816357)

“…No significant difference was observed between the two populations. The mean expansion time to passage 4 was 58.5 days (±18 days) for diabetic ASC versus 62.5 days (±28 days) for ND ASC (<i>p</i> = NS). …”

<i>Tg</i>G6PDH1, <i>Tg</i>G6PDH2, <i>Tg</i>6PGDH1, <i>Tg</i>RuPE and <i>Tg</i>TAL are dispensable for parasite growth and virulence, while <i>Tg</i>G6PDHs are required for defendin... by Ningbo Xia (13584299)

Shifts caused by control and Grin2c siRNAs in stimulation threshold and maximum response rate. by Giovanni Hernandez (236411)

“…<p><b>A-B)</b> Histogram bars represent means +/- SEM; saline injection in the VTA does not produces a reliable change in M50 nor MAX <b>C)</b> Treatment with the control siRNA did not produce a significant change in the stimulation threshold (M50), but the treatment with the siRNA against the Grin2c subunit produces a significant increase. …”

TrkB activation by HIOC and analogs: HIFN <i>vs</i> HIOC. by Shweta Modgil (12864344)

Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study by Jung-Ick Byun (554902)

“…Seizure frequency was evaluated at 2–4 weeks and 6 months after the onset of the initial immunotherapy and was categorized as “seizure remission”, “> 50% seizure reduction”, or “no change” based on the degree of its decrease.…”